Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Feith

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Molecular Cancer Research : MCR|November 21, 2019
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and <i>MCL-1</i> Splicing to Induce Apoptosis in Acute Myeloid LeukemiaJennifer M Pearson, Su-Fern Tan, Arati Sharma, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Journal of Lipid Research|April 10, 2019
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulationSu-Fern Tan, Wendy Dunton, Xin Liu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte LeukemiaIpsita Pal, Anuradha Illendula, Andrea Joyner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemiaKelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Cancers|December 23, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Journal of Lipid Research|May 4, 2016
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaSamy A F Morad, Terence E Ryan, P Darrell Neufer, et al.
Blood|September 2, 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell LymphomaIpsita Pal, Anuradha Illendula, Andrea Megan Joyner, et al.
Blood|January 11, 2022
Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemiaHeeJin Cheon, Jeffrey C Xing, Katharine B Moosic, et al.
Plos One|December 25, 2013
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemiaLindsay K Ryland, Ushma A Doshi, Sriram S Shanmugavelandy, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Molecular Cancer Research : MCR|November 21, 2019
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and <i>MCL-1</i> Splicing to Induce Apoptosis in Acute Myeloid LeukemiaJennifer M Pearson, Su-Fern Tan, Arati Sharma, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Journal of Lipid Research|April 10, 2019
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulationSu-Fern Tan, Wendy Dunton, Xin Liu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte LeukemiaIpsita Pal, Anuradha Illendula, Andrea Joyner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 10, 2021
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemiaKelsey H Fisher-Wellman, James T Hagen, Miki Kassai, et al.
Cancers|December 23, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Journal of Lipid Research|May 4, 2016
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaSamy A F Morad, Terence E Ryan, P Darrell Neufer, et al.
Blood|September 2, 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell LymphomaIpsita Pal, Anuradha Illendula, Andrea Megan Joyner, et al.
Blood|January 11, 2022
Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemiaHeeJin Cheon, Jeffrey C Xing, Katharine B Moosic, et al.
Plos One|December 25, 2013
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemiaLindsay K Ryland, Ushma A Doshi, Sriram S Shanmugavelandy, et al.
Pageof 8